| Dr Alicia Renee Allen, MD | |
|
1651 Gunbarrel Rd Ste 201, Chattanooga, TN 37421-3291 | |
| (423) 899-9133 | |
| (423) 855-8176 |
| Full Name | Dr Alicia Renee Allen |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 16 Years |
| Location | 1651 Gunbarrel Rd Ste 201, Chattanooga, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013189067 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 46749 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Erlanger Medical Center | Chattanooga, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Galen Medical Group, Pc | 2668377391 | 126 |
News Archive
A team of USA Today reporters spent a full, 24-hour day in the emergency room at University of Virginia Medical Center in late August. "The key elements of today's debate on health care converge in the ER, from the cutting-edge quality of the U.S. system to the millions of uninsured people who show up for care," according to the report. A key reform goal is covering an estimated 46 million uninsured Americans. But the task is expensive, and in many cases, born by ERs under the current system.
Bioconnect Systems, Inc. announced today that data from the Company's first clinical study will be presented this week at the ASN Meeting in San Diego. Bioconnect's implant platform, the Optiflow™, enhances a surgeon's ability to create precise vascular connections.
The use of electronic reminders such as text messages, emails or voicemails is highly effective at getting surgical patients to adhere to a preadmission antiseptic showering regimen known to help reduce risk of surgical site infections (SSIs), according to a first-of-its-kind study published in the August issue of the Journal of the American College of Surgeons.
TARGET PharmaSolutions, Inc., a company focused on real-world evidence, is pleased to announce that Bristol Myers Squibb has entered into a strategic partnership for TARGET-IBD.
Echo Therapeutics, Inc., a company developing its needle-free Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that a 1-for-10 reverse split of the Company's issued and outstanding common stock will be effective prior to the market opening on Friday, June 7, 2013.
› Verified 1 days ago
| Entity Name | Galen Medical Group, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346250057 PECOS PAC ID: 2668377391 Enrollment ID: O20031204001027 |
News Archive
A team of USA Today reporters spent a full, 24-hour day in the emergency room at University of Virginia Medical Center in late August. "The key elements of today's debate on health care converge in the ER, from the cutting-edge quality of the U.S. system to the millions of uninsured people who show up for care," according to the report. A key reform goal is covering an estimated 46 million uninsured Americans. But the task is expensive, and in many cases, born by ERs under the current system.
Bioconnect Systems, Inc. announced today that data from the Company's first clinical study will be presented this week at the ASN Meeting in San Diego. Bioconnect's implant platform, the Optiflow™, enhances a surgeon's ability to create precise vascular connections.
The use of electronic reminders such as text messages, emails or voicemails is highly effective at getting surgical patients to adhere to a preadmission antiseptic showering regimen known to help reduce risk of surgical site infections (SSIs), according to a first-of-its-kind study published in the August issue of the Journal of the American College of Surgeons.
TARGET PharmaSolutions, Inc., a company focused on real-world evidence, is pleased to announce that Bristol Myers Squibb has entered into a strategic partnership for TARGET-IBD.
Echo Therapeutics, Inc., a company developing its needle-free Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that a 1-for-10 reverse split of the Company's issued and outstanding common stock will be effective prior to the market opening on Friday, June 7, 2013.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alicia Renee Allen, MD 4976 Alpha Ln, Hixson, TN 37343-5470 Ph: (423) 497-5355 | Dr Alicia Renee Allen, MD 1651 Gunbarrel Rd Ste 201, Chattanooga, TN 37421-3291 Ph: (423) 899-9133 |
News Archive
A team of USA Today reporters spent a full, 24-hour day in the emergency room at University of Virginia Medical Center in late August. "The key elements of today's debate on health care converge in the ER, from the cutting-edge quality of the U.S. system to the millions of uninsured people who show up for care," according to the report. A key reform goal is covering an estimated 46 million uninsured Americans. But the task is expensive, and in many cases, born by ERs under the current system.
Bioconnect Systems, Inc. announced today that data from the Company's first clinical study will be presented this week at the ASN Meeting in San Diego. Bioconnect's implant platform, the Optiflow™, enhances a surgeon's ability to create precise vascular connections.
The use of electronic reminders such as text messages, emails or voicemails is highly effective at getting surgical patients to adhere to a preadmission antiseptic showering regimen known to help reduce risk of surgical site infections (SSIs), according to a first-of-its-kind study published in the August issue of the Journal of the American College of Surgeons.
TARGET PharmaSolutions, Inc., a company focused on real-world evidence, is pleased to announce that Bristol Myers Squibb has entered into a strategic partnership for TARGET-IBD.
Echo Therapeutics, Inc., a company developing its needle-free Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that a 1-for-10 reverse split of the Company's issued and outstanding common stock will be effective prior to the market opening on Friday, June 7, 2013.
› Verified 1 days ago
John Sindos Adams Sr., MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 929 Spring Creek Road, Suite 104, Chattanooga, TN 37412 Phone: 423-510-0250 Fax: 423-510-9524 | |
Dr. Charles Patrick Johnson, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1751 Gunbarrel Rd, Suite 101, Chattanooga, TN 37421 Phone: 423-778-8558 Fax: 423-778-8560 | |
Dr. William Joel Moss, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1755 Gunbarrel Rd, Suite 205, Chattanooga, TN 37421 Phone: 423-756-0863 Fax: 706-937-2377 | |
Mr. Gary A. Brunvoll, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7490 Ziegler Rd, Chattanooga, TN 37421 Phone: 423-648-6020 Fax: 423-648-6025 | |
Elizabeth Maria Bowers, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1751 Gunbarrel Road, Suite 100, Chattanooga, TN 37421 Phone: 423-778-9500 Fax: 423-778-8882 | |
Porche' Warren Adams, DO, MPH Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 935 Spring Creek Rd Ste 100, Chattanooga, TN 37412 Phone: 423-510-0250 Fax: 423-510-9524 |